Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Androgen receptor localisation and protein interactions provide insight into steroid mediated metabolic shifts in endocrine resistant breast cancer.

NPJ breast cancer·2026
Same author

Assessment and classification of sex cord-stromal tumours of the testis: recommendations from the testicular sex cord-stromal tumour (TESST) group, an Expert Panel of the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP).

Histopathology·2025
Same author

Histologic- and Genomic-Directed Adjuvant Therapy for Ampullary Adenocarcinoma: A Hidden Genome-Derived Analysis.

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same author

Federated Deep Learning Enables Cancer Subtyping by Proteomics.

Cancer discovery·2025
Same author

Observer Variation in the Diagnosis of Testicular Sex Cord-Stromal Tumors by a Genitourinary Pathology Society and International Society of Urological Pathology Panel: Paving the Way for a New Classification.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

Adjuvant External Beam Radiotherapy Reduces Local Recurrence in Poorly Differentiated Thyroid Cancer : A Multicenter Retrospective Cohort Study Describing Outcomes in the Treatment of Resectable Poorly Differentiated Thyroid Cancer.

Annals of surgical oncology·2025

Related Experiment Video

Updated: Dec 24, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.4K

NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm.

Daniel D Wong1, Ana Cristina Vargas2, Fiona Bonar3

  • 1Anatomical Pathology, PathWest, QEII Medical Centre, Nedlands, WA, Australia; School of Medicine, The University of Western Australia, Crawley, WA, Australia.

Pathology
|April 13, 2020
PubMed
Summary

Oncogenic NTRK gene fusions are found in rare mesenchymal tumors, posing diagnostic challenges. Early detection is crucial for effective targeted therapy in advanced sarcomas.

Keywords:
NTRKTRKentrectiniblarotrectinibmesenchymal tumourspan-TRKsarcomasoft tissue tumours

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.5K

Related Experiment Videos

Last Updated: Dec 24, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.4K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.5K

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Neurotrophic receptor tyrosine kinase (NTRK) gene fusions are increasingly recognized in various mesenchymal tumors beyond their initial description.
  • These NTRK-rearranged neoplasms present diagnostic difficulties for pathologists due to non-specific clinical and pathological features.

Observation:

  • This study details six rare NTRK-rearranged mesenchymal neoplasms from an Australian multi-institutional series.
  • Key morphological patterns and immunoprofiles aiding in routine diagnosis are highlighted.

Findings:

  • The study addresses the diagnostic challenges posed by NTRK-rearranged mesenchymal tumors.
  • It emphasizes the importance of recognizing these fusions for targeted therapy in advanced and metastatic sarcomas.

Implications:

  • Accurate identification of NTRK fusions is critical for guiding treatment decisions with targeted therapies.
  • The proposed diagnostic algorithm aims to assist pathologists, acknowledging limitations of current ancillary studies like IHC, FISH, and NGS.